Eleven Biotherapeutics, Inc. EBIO
— —
At closeJun 28, 2019, 6:07 PM EDT
Day range unavailable
52-week range unavailable
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 9, 2018 | Laidlaw & Co. | init | — | Buy |
| Mar 19, 2018 | H.C. Wainwright | init | — | Buy |
| Jan 18, 2016 | Leerink Swann | down | — | Market Perform |
| Mar 2, 2014 | Citigroup | init | — | Buy |
| Mar 2, 2014 | Cowen & Co. | init | — | Outperform |
| Mar 2, 2014 | Citigroup | init | — | Buy |
News
Your note
Sign in to keep a note on EBIO — it syncs with the Stock Master app.